Patent ID: 11938120
Assignee: KING FAISAL UNIVERSITY
Field: Pharmaceuticals (Chemistry)
Classification: CPC A | IPC A

Claim 13:
14. A method of treating tuberculosis in a patient, comprising administering to a patient in need thereof a therapeutically effective amount of a compound selected from the group consisting of:
Ethyl 7-methyl-1-(4-methylbenzoyl)pyrrolo[1,2-a]quinoline-3-carboxylate (4a);
Ethyl 1-benzoyl-7-methylpyrrolo[1,2-a]quinoline-3-carboxylate (4b);
Ethyl 1-(4-fluorobenzoyl)-7-methylpyrrolo[1,2-a]quinoline-3-carboxylate (4c);
Ethyl 7-methyl-1-(2-nitrobenzoyl)pyrrolo[1,2-a]quinoline-3-carboxylate (4d);
Ethyl 1-(4-bromobenzoyl)-7-methylpyrrolo[1,2-a]quinoline-3-carboxylate (4e);
Ethyl 1-(3,5-bis(trifluoromethyl)benzoyl)-7-methylpyrrolo[1,2-a]quinoline-3-carboxylate (4f);
and a pharmaceutically acceptable salt, or stereoisomer thereof.